• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PTEN 和 PHLPP 在癌细胞和 TGFβ 激活的干细胞中相互作用。

PTEN and PHLPP crosstalk in cancer cells and in TGFβ-activated stem cells.

机构信息

Institute of Environmental Medicine, Karolinska Institutet, S-171 77 Stockholm, Sweden.

Institute of Environmental Medicine, Karolinska Institutet, S-171 77 Stockholm, Sweden; Department of Pharmacology, Medical University of South Carolina, United States.

出版信息

Biomed Pharmacother. 2020 Jul;127:110112. doi: 10.1016/j.biopha.2020.110112. Epub 2020 Apr 12.

DOI:10.1016/j.biopha.2020.110112
PMID:32294598
Abstract

UNLABELLED

Akt kinase regulates several cellular processes, among them growth, proliferation and survival, and has been correlated to neoplastic disease. We report here crosstalk between several Akt regulatory phosphatases that controls the level of the activated form (phosphorylated) of Akt and affects tumor cell aggressiveness. In prostate cancer cell lines, we observed that transient transfection of PTEN decreased the endogenous level of PHLPPs and in contrast, the transient transfection of PHLPPs decreased the endogenous level of PTEN. Furthermore, silencing of PTEN by siRNA resulted in increased PHLPP levels. This phenomenon was not seen in non-transformed cells or in prostate stem cells. This crosstalk promoted cancer cell invasion and was controlled by epigenetically regulated processes where activation of miRs (miR-190 and miR214), the polycomb group of proteins and DNA methylation were involved. The purinergic P2X4 receptor, which has been shown to have a role in wound healing, was identified to be the mediator of this crosstalk. We also studied prostate stem cells and found this crosstalk in the TGFβ1-activated epithelial-mesenchymal transition (EMT). The crosstalk seemed to be a natural part of EMT. In summary, we identify a crosstalk between Akt phosphatases which is not present in non-transformed prostate cells but occurs in cancer cells and stem cells transformed by TGFβ-1. This crosstalk is important for cellular invasion.

BACKGROUND

Phosphatases regulate the Akt oncogene.

RESULTS

Crosstalk between Akt phosphatases in prostate cancer cells and in TGF-β1 activated stem cells but not in non-transformed cells.

CONCLUSION

This back-up mechanism facilitates invasive migration of prostate stem and cancer cells.

SIGNIFICANCE

Characterization of Akt regulation may lead to a better understanding of tumor development and to novel strategies for treatment.

摘要

未标记

Akt 激酶调节多种细胞过程,包括生长、增殖和存活,并且与肿瘤疾病相关。我们在这里报告几种 Akt 调节磷酸酶之间的串扰,这些磷酸酶控制 Akt 的激活形式(磷酸化)的水平,并影响肿瘤细胞的侵袭性。在前列腺癌细胞系中,我们观察到瞬时转染 PTEN 降低了内源性 PHLPPs 的水平,而相反,瞬时转染 PHLPPs 降低了内源性 PTEN 的水平。此外,siRNA 沉默 PTEN 导致 PHLPP 水平升高。这种现象在未转化细胞或前列腺干细胞中没有出现。这种串扰促进了癌细胞的侵袭,并受表观遗传调控过程的控制,其中涉及 miR(miR-190 和 miR214)、多梳蛋白组蛋白和 DNA 甲基化的激活。已显示嘌呤能 P2X4 受体在伤口愈合中起作用,被鉴定为这种串扰的介导物。我们还研究了前列腺干细胞,在 TGFβ1 激活的上皮-间充质转化(EMT)中发现了这种串扰。这种串扰似乎是 EMT 的自然组成部分。总之,我们鉴定了 Akt 磷酸酶之间的串扰,这种串扰在非转化的前列腺细胞中不存在,但在 TGFβ-1 转化的癌细胞和干细胞中存在。这种串扰对于细胞侵袭很重要。

背景

磷酸酶调节 Akt 癌基因。

结果

前列腺癌细胞和 TGF-β1 激活的干细胞中 Akt 磷酸酶之间的串扰,但在非转化细胞中不存在。

结论

这种备份机制促进了前列腺干细胞和癌细胞的侵袭性迁移。

意义

对 Akt 调节的表征可能导致对肿瘤发展的更好理解,并为治疗提供新策略。

相似文献

1
PTEN and PHLPP crosstalk in cancer cells and in TGFβ-activated stem cells.PTEN 和 PHLPP 在癌细胞和 TGFβ 激活的干细胞中相互作用。
Biomed Pharmacother. 2020 Jul;127:110112. doi: 10.1016/j.biopha.2020.110112. Epub 2020 Apr 12.
2
Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and PH domain and leucine-rich repeat phosphatase cross-talk (PHLPP) in cancer cells and in transforming growth factor β-activated stem cells.抑癌基因第 10 号染色体缺失磷酸酶及张力蛋白同源物(PTEN)和 PH 结构域及亮氨酸丰富重复磷酸酶相互作用(PHLPP)在癌细胞和转化生长因子 β 激活的干细胞中的作用。
J Biol Chem. 2014 Apr 25;289(17):11601-11616. doi: 10.1074/jbc.M113.537241. Epub 2014 Mar 5.
3
Relationship between polycomb-group protein BMI-1 and phosphatases regulating AKT phosphorylation level in endometrial cancer.子宫内膜癌中多梳蛋白家族蛋白 BMI-1 与调节 AKT 磷酸化水平的磷酸酶之间的关系。
J Cell Mol Med. 2020 Jan;24(2):1300-1310. doi: 10.1111/jcmm.14782. Epub 2019 Dec 21.
4
PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.PHLPP 是 RAF1 的负调控因子,可降低结直肠癌细胞的迁移能力,并防止小鼠肿瘤进展。
Gastroenterology. 2014 May;146(5):1301-12.e1-10. doi: 10.1053/j.gastro.2014.02.003. Epub 2014 Feb 11.
5
PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma.PTEN、NHERF1 和 PHLPP 形成一个肿瘤抑制因子网络,该网络在神经胶质瘤中失活。
Oncogene. 2012 Mar 8;31(10):1264-74. doi: 10.1038/onc.2011.324. Epub 2011 Aug 1.
6
Effects of PTEN gene silencing on invasion and EMT in oral squamous carcinoma Tca8113 cells.PTEN基因沉默对口腔鳞状细胞癌Tca8113细胞侵袭和上皮-间质转化的影响。
J Oral Pathol Med. 2017 Jan;46(1):31-38. doi: 10.1111/jop.12461. Epub 2016 Sep 3.
7
Direct regulation of transforming growth factor β-induced epithelial-mesenchymal transition by the protein phosphatase activity of unphosphorylated PTEN in lung cancer cells.未磷酸化的PTEN蛋白磷酸酶活性对肺癌细胞中转化生长因子β诱导的上皮-间质转化的直接调控
Cancer Sci. 2015 Dec;106(12):1693-704. doi: 10.1111/cas.12831. Epub 2015 Nov 6.
8
The crosstalk between p38 and Akt signaling pathways orchestrates EMT by regulating SATB2 expression in NSCLC cells.p38与Akt信号通路之间的串扰通过调节非小细胞肺癌(NSCLC)细胞中SATB2的表达来协调上皮-间质转化(EMT)。
Tumour Biol. 2017 Sep;39(9):1010428317706212. doi: 10.1177/1010428317706212.
9
CXADR-Mediated Formation of an AKT Inhibitory Signalosome at Tight Junctions Controls Epithelial-Mesenchymal Plasticity in Breast Cancer.CXADR 介导的紧密连接处 AKT 抑制信号复合物的形成控制乳腺癌中的上皮-间充质转化。
Cancer Res. 2019 Jan 1;79(1):47-60. doi: 10.1158/0008-5472.CAN-18-1742. Epub 2018 Nov 1.
10
The phosphatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation.磷酸酶 PHLPP1 调控 Akt2,促进胰腺癌细胞死亡,并抑制肿瘤形成。
Gastroenterology. 2012 Feb;142(2):377-87.e1-5. doi: 10.1053/j.gastro.2011.10.026. Epub 2011 Oct 29.

引用本文的文献

1
Emerging roles of PHLPP phosphatases in lung cancer.PHLPP磷酸酶在肺癌中的新作用。
Front Oncol. 2023 Jul 27;13:1216131. doi: 10.3389/fonc.2023.1216131. eCollection 2023.
2
Construction of a novel cuproptosis-related gene signature for predicting prognosis and estimating tumor immune microenvironment status in papillary thyroid carcinoma.构建新型铜死亡相关基因signature,用于预测甲状腺乳头状癌的预后和估计肿瘤免疫微环境状态。
BMC Cancer. 2022 Nov 4;22(1):1131. doi: 10.1186/s12885-022-10175-5.
3
P2 purinergic receptor dysregulation in urologic disease.
P2 嘌呤能受体失调与泌尿系统疾病。
Purinergic Signal. 2022 Sep;18(3):267-287. doi: 10.1007/s11302-022-09875-1. Epub 2022 Jun 10.
4
P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer.P2X4 嘌呤能受体为侵袭性前列腺癌提供了一个治疗靶点。
J Pathol. 2022 Feb;256(2):149-163. doi: 10.1002/path.5815. Epub 2021 Nov 25.
5
Inhibiting the P2X4 Receptor Suppresses Prostate Cancer Growth In Vitro and In Vivo, Suggesting a Potential Clinical Target.抑制 P2X4 受体可抑制前列腺癌的体外和体内生长,提示其可能成为临床治疗靶点。
Cells. 2020 Nov 20;9(11):2511. doi: 10.3390/cells9112511.